Carcinoma-associated MUC1 detected by immunoradiometric assays

Tumor Biology

Volumn 19, Issue SUPPL.1, 1997, Pages 134-146

  Norum, Lars F ^a   Varaas, Tone ^a   Kierulf, Bente ^a   Nustad, Kjell ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antibody specificity; Immunoassay; Monoclonal antibodies; MUC1

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; CANCER DIAGNOSIS; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; GLYCOSYLATION; IMMUNORADIOMETRIC ASSAY; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; TANDEM REPEAT;

EID: 0031443144     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056515     Document Type: Conference Paper

References (36)

1. Hammarström S, Shively JE, Paxton RJ, Beatty BG, Larsson A, Ghosh R, Bormer O, Buchegger F, Mach J-P, Burtin P, Seguin P, Darbouret B, Degorce F, Sertour J, Jolu JP, Fuks A, Kalthoff H, Schmiegel W, Arndt R, Kloppel G, von Kleist S, Grunert F, Schwarz K, Matsuoka Y, Kuroki M, Wagener C, Weber T, Yachi A, Imai K, Hisnikawa N, Tsujisaki M: Antigenic sites in carcinoembryonic antigen. Cancer Res 1989;49:4852-4858.
2. Nap M, Hammarström M-L, Börmer O, Hammarström S, Wagener C, Handt S, Schreyer M, Mach J-P, Buchegger F, von Kleist S, Grunert F, Seguin P, Fuks A, Holm R, Lamerz R: Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res 1992;52-2329-2339.
3. Nap M, Vitali A, Nustad K, Bast RC Jr, O'Brien TJ, Nilsson O, Seguin P, Suresh MR, Børmer OP, Saga T, De Bruijn HWA, Nozawa S, Kreutz FJ, Jette D, Sakahara H, Gadnell M, Endo K, Barlow EH, Warren D, Paus E, Hammarström S, Kenemans P, Hilgers J: Immunohistochemical characterization of 22 monoclonal antibodies against the CA 125 antigen. Second Report from the ISOBM TD-1 Workshop. Tumor Biol 1996;17:325-331.
4. Nustad K, Bast RC Jr, O'Brien T, Nilsson O, Segum P, Suresh MR, Saga T, Nozawa S, Børmer OP, De Bruijn HWA, Nap M, Vitali A, Gadnell M, Clark J, Shigemasa K, Karlsson B, Kreutz FJ, Jette D, Sakahara H, Endo K, Paus E, Warren D, Hammarström S, Kenemans P, Hilgers J. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen. First Report from the ISOBM TD-1 Workshop. Tumor Biol 1996;17:196-219.
5. Hilkens J: CA 15-3 assay for the detection of episialin; in Sell S (ed): Serological Cancer Markers. Totowa, Humana Press, 1992, pp 261-280
6. Brockhausen I, Yang JM, Burchell J, Whitehouse C, Taylor-Papadimitriou J: Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem 1995;233:607-617.
7. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani EN, Wilson D: Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol chem 1990;265:15286-15293.
8. Ligtenberg MJ, Vos HL, Gennissen AM, Hilkens J: Episialin, a carcinoma-associated mucin. is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem 1990;265:5573-5578.
9. Burchell J, Taylor-Papadimitriou J, Boshell M, Gendler S, Duhig T: A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int J Cancer 1989;44:691-696.
10. Zrihan-Licht S, Vos HL, Baruch A, Elroy-Stein O, Sagiv D, Keydar I, Hilkens J, Wreschner DH: Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue. Eur J Biochem 1994;224-787-795.
11. Burchell J, Taylor-Papadimitriou J: Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell Biol 1993;2:155-162.
12. Paus E, Nustad K, Børmer OP: Epitope mapping and affinity estimation of the ISOBM antibodies against prostate-specific antigen. Tumor Biol 1998, submitted.
13. Andrew SM, Titus JA: Purification and fragmentation of antibodies; in Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds): Current Protocols in Immunology. New York, Wiley, 1996, pp 2.7 1-2.7.12.
14. 2-macroglobulin by affinity chromatography on immobilized snowdrop bulb lectin. Arch Biochem Biophys 1988;267:676-680
15. Smeland E, Funderud S, Ruud E, Blomhoff HK, Godal T: Characterization of two murine monoclonal antibodies reactive with human B cells. Their use in a high-yield, high-purity method for isolation of B cells and utilization of such cells in an assay for B-cell stimulating factor. Scand J Immunol 1985;21:205-214.
16. Frengen J, Schmid R, Kierulf B, Nustad K, Paus E, Berge A, Lindmo T: Homogeneous immunofluorometric assays of α-fetoprotein with macroporous, monosized particles and flow cytometry. Clin Chem 1993;39:2174-2181.
17. Kvalheim G, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S: Elimination of B-lymphoma cells from human bone marrow: Model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer Res 1987;47:846-851.
18. Paus E, Børmer O, Nustad K: Radioiodination of proteins with the iodogen method; in Radioimmunoassay and Related Procedures in Medicine 1982. Vienna, International Atomic Energy Agency, 1982, pp 161-171.
19. Frengen J, Kierulf B, Schmid R, Lindmo T, Nustad K: Demonstration and minimization of serum interference in flow cytometric two-site immunoassays. Clin Chem 1994;40:420-425.
20. Børmer OP, Nustad K: Selection of monoclonal antibodies for use in an immunometric assay for carcinoembryonic antigen. J Immunol Methods 1990;127:171-178.
21. Nilsson O, Karlsson B, Lindholm L, Pettersson A: Development of assays for determination of MUC-1 breast cancer antigen; in Klapdor R (ed): Current Tumor Diagnosis: Applications. Clinical Relevance. Research Trends. Munich, Zuckschwerdt, 1994, pp 130-133.
22. Murray A, Clinton O, Earl H, Price M, Moore A: Assessment of five serum marker assays in patients with advanced breast cancer treated with medroxyprogesterone acetate. Eur J Cancer [A] 1995;31A:1605-1610.
23. McGuckin MA, Layton GT, Bailey MJ, Hurst T, Khoo SK, Ward BG: Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma - comparison with CA 125. Gynecol Oncol 1990;37:165-171.
24. Tobias R, Rothwell C, Wagner J, Green A, Liu Y: Development and evaluation of a radioimmunoassay for the detection of a monoclonal antibody defined breast tumor associated antigen 115D8/DF3 (abstract). Clin Chem 1985;31:986.
25. Hayes DF, Sekine H, Ohno T, Abe M, Keefe K, Kufe DW: Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest 1985;75:1671-1678.
26. Hayes DF, Zurawski VR Jr, Kufe DW: Comparison of circulating CA 15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 1986;4:1542-1550.
27. Martinez L, Castilla JA, Blanco N, Perán F, Herruzo A: CA 125, CA15.3, CA 27.29, CEA, β-hCG and α-fetoprotein levels in cyst fluid of breast macrocysts. Int J Gynecol Obstet 1995;48:187-192.
28. Brown JP, Linsley PS, Horn D: Development and evaluation of monoclonal antibody-based immunoassays: Breast carcinoma-associated mucins as tumor markers. Immunol Ser 1990;53:69-82.
29. Stacker SA, Thompson CH, Lowe MG, Sacks NP, Golder J, Carmen H, McKenzie IF. Mammary serum antigen levels as a marker for breast cancer: A survey of blood donors and patients with cancer. Dev Biol Stand 1987;67:91-96.
30. Hilkens J, Kroezen V, Bonfrer JM, de Jong-Bakker M, Bruning PF: MAM-6 antigen, a new serum marker for breast cancer monitoring. Cancer Res 1986;46:2582-2587.
31. Bray KR, Koda JE, Gaur PK: Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker. Cancer Res 1987;47:5853-5860.
32. Gendler S, Burchell J, Griffiths AB, Taylor-Papadimitriou J: Molecular and immunological analysis of mucin molecules produced by normal and malignant human mammary epithelial cells; in Ceriani RL (ed): Immunological Approaches to the Diagnosis and Therapy of Breast Cancer. New York, Plenum Press, 1987, pp 33-40.
33. Iwanari O, Miyako J, Date Y, Nakayama S, Kijima S, Moriyama M, Takahashi K, Yoshmo N, Karino K, Endoh J, et al: Differential diagnosis of ovarian cancer, benign ovarian tumor and endometriosis by a combination assay of serum sialyl SSEA-1 antigen and CA 125 levels. Gynecol Obstet Invest 1990;29:71-74.
34. Burchell J, Wang D, Taylor-Papadimitriou J: Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer. Int J Cancer 1984;34:763-768.
35. Stähli C, Caravatti M, Aeschbacher M, Kocyba C, Takacs B, Carmann H: Mucin-like carcinoma-associated antigen defined by three monoclonal antibodies against different epitopes. Cancer Res 1988;48:6799-6802.
36. Dixon AR, Price MR, Hand CW, Sibley PE, Selby C, Blarney RW: Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer - a comparison with CA 15.3. Br J Cancer 1993;68:947-949.